Applying a discriminant score (QDA) showed that the marker set including CK19, p1B, EGP2 and SBEM gave the most significant separation between tumour cell negative and positive ALNs with zero misclassified control lymph nodes (P<0.0001). This evidence concerns the gene EPCAM and neoplasm.